<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37468884</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UK.</ArticleTitle><Pagination><StartPage>259</StartPage><MedlinePgn>259</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-023-02897-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">To determine the extent and nature of changes associated with COVID-19 infection in terms of healthcare utilisation, this study observed healthcare contact 1 to 4 and 5 to 24&#xa0;weeks following a COVID-19 diagnosis compared to propensity-matched controls.</AbstractText><AbstractText Label="METHODS">Two hundred forty nine thousand three hundred ninety Welsh individuals with a positive reverse transcription-polymerase chain reaction (RT-PCR) test were identified from data from national PCR test results. After elimination criteria, 98,600 positive individuals were matched to test negative and never tested controls using propensity matching. Cohorts were split on test location. Tests could be taken in either the hospital or community. Controls were those who had tested negative in their respective environments. Survival analysis was utilised for first clinical outcomes which are grouped into primary and secondary. Primary outcomes include post-viral-illness and fatigue as an indication of long-COVID. Secondary outcomes include clinical terminology concepts for embolism, respiratory conditions, mental health conditions, fit notes, or hospital attendance. Increased instantaneous risk for positive individuals was quantified using hazard ratios (HR) from Cox regression, while absolute risk (AR) and relative risk were quantified using life table analysis.</AbstractText><AbstractText Label="RESULTS">Analysis was conducted using all individuals and stratified by test location. Cases are compared to controls from the same test location. Fatigue (HR: 1.77, 95% CI: 1.34-2.25, p&#x2009;=&#x2009;&#x2009;&lt;&#x2009;0.001) and embolism (HR: 1.50, 95% CI: 1.15-1.97, p&#x2009;=&#x2009;0.003) were more likely to occur in all positive individuals in the first 4&#xa0;weeks; however, anxiety and depression (HR: 0.83, 95% CI: 0.73-0.95, p&#x2009;=&#x2009;0.007) were less likely. Positive individuals continued to be more at risk of fatigue (HR: 1.47, 95% CI: 1.24-1.75, p&#x2009;=&#x2009;&#x2009;&lt;&#x2009;0.001) and embolism (HR: 1.51, 95% CI: 1.13-2.02, p&#x2009;=&#x2009;0.005) after 4&#xa0;weeks. All positive individuals are also at greater risk of post-viral illness (HR: 4.57, 95% CI: 1.77-11.80, p&#x2009;=&#x2009;0.002). Despite statistical association between testing positive and several conditions, life table analysis shows that only a small minority of the study population were affected.</AbstractText><AbstractText Label="CONCLUSIONS">Community COVID-19 disease is associated with increased risks of post-viral-illness, fatigue, embolism, and respiratory conditions. Despite elevated risks, the absolute healthcare burden is low. Subsequently, either very small proportions of people experience adverse outcomes following COVID-19 or they are not presenting to healthcare.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK. m.j.parker@swansea.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seaborne</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mhereeg</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Datalab, Nuffield Dept of Primary Care Health Science, Radcliffe Primary Care Building, Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denaxas</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Health Informatics, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Katikireddi</LastName><ForeName>S V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brophy</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Centre for Population Health and Wellbeing Research, Swansea University Medical School, Swansea, Wales, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00011/4</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00022/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SPHSU17</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>COV-LT-0009</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HDR-9006</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014852" MajorTopicYN="N" Type="Geographic">Wales</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Health data</Keyword><Keyword MajorTopicYN="N">Long&#x2013;COVID</Keyword><Keyword MajorTopicYN="N">Routine data</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37468884</ArticleId><ArticleId IdType="pmc">PMC10354936</ArticleId><ArticleId IdType="doi">10.1186/s12916-023-02897-5</ArticleId><ArticleId IdType="pii">10.1186/s12916-023-02897-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drew DA, Nguyen LH, Steves CJ, Menni C, Freydin M, Varsavsky T, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 1979;2020(368):1362&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200009</ArticleId><ArticleId IdType="pubmed">32371477</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370.&#xa0;10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2022;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Original research: multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:48391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4august2022. Accessed 22 Aug 2022.</Citation></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with cOVID-19. Ann Intern Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam N, Madathil S, Tahani N, Bolton S, Parekh D, Stockley J, et al. Medium-term outcomes in severely to critically ill patients with severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2022;74:301. doi: 10.1093/cid/ciab341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab341</ArticleId><ArticleId IdType="pmc">PMC8135551</ArticleId><ArticleId IdType="pubmed">33893486</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:1&#x2013;11. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15:869. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x201c;right&#x201d; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4:1&#x2013;12. doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:7821. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van HM, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;2020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker HR, Gulea C, Koteci A, Kallis C, Morgan AD, Iwundu C, et al. GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study. BMJ. 2021;375.&#xa0;10.1136/bmj-2021-065834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KH, Ford D V., Thompson S, Lyons RA. A profile of the SAIL databank on the UK secure research platform. Int J Popul Data Sci. 2019;4. 10.23889/ijpds.v4i2.1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142954</ArticleId><ArticleId IdType="pubmed">34095541</ArticleId></ArticleIdList></Reference><Reference><Citation>SAIL Databank benchmarked against leading European health data research platforms - SAIL Databank. https://saildatabank.com/sail-databank-benchmarked-against-leading-european-health-data-research-platforms/. Accessed 29 Mar 2023.</Citation></Reference><Reference><Citation>NHS Digital. Read Codes. https://digital.nhs.uk/services/terminology-and-classifications/read-codes. Accessed 16 Feb 2022.</Citation></Reference><Reference><Citation>Therneau T. A package for survival analysis in R. 2021.</Citation></Reference><Reference><Citation>Eclipse Foundation Inc. Eclipse SDK. 2019.</Citation></Reference><Reference><Citation>RStudio Team . RStudio | Open source &amp; professional software for data science teams - RStudio. 2021.</Citation></Reference><Reference><Citation>Kassambara A, Kosinski M, Biecek P. survminer: drawing survival curves using &#x201c;ggplot2.&#x201d;. 2021.</Citation></Reference><Reference><Citation>Greifer N. cobalt: covariate balance tables and plots. 2022.</Citation></Reference><Reference><Citation>NHS Wales: Record waiting times for 19th successive month - BBC News. https://www.bbc.co.uk/news/uk-wales-60067732. Accessed 31 Aug 2022.</Citation></Reference><Reference><Citation>Testing data for coronavirus (COVID-19) | GOV.WALES. https://gov.wales/testing-data-coronavirus-covid-19. Accessed 31 Aug 2022.</Citation></Reference><Reference><Citation>Rivera-Izquierdo M, L&#xe1;inez-Ramos-Bossini AJ, de Alba IG-F, Ortiz-Gonz&#xe1;lez-Serna R, Serrano-Ortiz &#xc1;, Fern&#xe1;ndez-Mart&#xed;nez NF, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20.&#xa0;https://pubmed.ncbi.nlm.nih.gov/35193574/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;2022:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers SE, Demmler JC, Dsilva R, Lyons RA. Protecting health data privacy while using residence-based environment and demographic data. Health Place. 2012;18:209&#x2013;217. doi: 10.1016/j.healthplace.2011.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthplace.2011.09.006</ArticleId><ArticleId IdType="pubmed">21996431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons RA, Ford DV, Moore L, Rodgers SE. Use of data linkage to measure the population health effect of non-health-care interventions. The Lancet. 2014;383:1517&#x2013;1519. doi: 10.1016/S0140-6736(13)61750-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61750-X</ArticleId><ArticleId IdType="pubmed">24290768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>